Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market. The post Why Is Medtronic Spinning Off Its Diabetes Business? appeared first on MedCity…
Untreated dental problems are driving millions of Americans to emergency rooms each year, costing the country billions and worsening chronic health conditions. Experts say bridging the historic divide between medical and dental care — through data connectivity, integrated health centers and AI-driven tools — could improve patient outcomes and reduce healthcare spending. The post From…
State, federal, and academic initiatives have poured time and resources into understanding and addressing these gaps. So why haven’t we made real, lasting progress? The post The Broken Approach to Health Disparities appeared first on MedCity News.
Alejandro Santillan-Garcia is worried he’s going to lose the aid that helps him buy food. The 20-year-old Austin resident qualified for federal food benefits last year because he aged out of the Texas foster care system, which he entered as an infant. The Supplemental Nutrition Assistance Program — commonly referred to as food stamps, or…
In Maine, state health officials hoped to steer a slice of $190 million in new federal rural health funding to shield hospitals and clinics from the fallout caused by cuts to federal health programs. Their plan would have helped pay to treat low-income, uninsured patients. But federal leaders overseeing the five-year, $50 billion Rural Health…
Charity Tarn, an investor with Arboretum Ventures, will be one of the investor judges for the Pitch Perfect contest at INVEST in Chicago May 20-21. Register today! The post Arboretum Ventures Investor Says Startups Are Adapting to Tough Healthcare Fundraising Environment appeared first on MedCity News.
Sanofi is licensing a RadioMedix radiopharmaceutical in development for neuroendocrine tumors. The French pharmaceutical giant is responsible for global commercialization of the therapy, a potential competitor to the Novartis radiopharmaceutical Lutathera. The post Sanofi Jumps Into Radiopharmaceuticals, Paying €100M for Therapy That Could Rival a Novartis Drug appeared first on MedCity News.
A paper by Ng, Zhang and Kowal (2025) use the American Community Survey (ACS) data from 2016–2022 were used to construct Social Vulnerability Index (SVI). SVI is calculated from 16 social determinants of health (SDoH) variables that are grouped into 4 themes: socioeconomic status, household characteristics, racial and ethnic minority status, and housing type &…
Pfizer said a patient dosed with danuglipron developed potential drug-induced liver injury. Pfizer is stopping further work on this program, a move that comes nearly two years after it discontinued development of a different obesity drug due to liver safety signals in a clinical trial. The post Pfizer Stops Work on Oral GLP-1 Obesity Drug…
North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers efficacy and tolerability advantages over Sanofi’s immune disorder juggernaut, Dupixent. The post North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug appeared first…